Literature DB >> 23975381

Fatigue interference with daily living among patients with inflammatory bowel disease.

Randi Opheim1, May Solveig Fagermoen, Tomm Bernklev, Lars-Petter Jelsness-Jorgensen, Bjorn Moum.   

Abstract

PURPOSE: The purpose of the study was to examine fatigue interference with daily living in patients with inflammatory bowel disease (IBD) and to explore relationships between severe fatigue interference and socio-demographic and clinical variables, including use of complementary and alternative medicine (CAM).
METHODS: Data were collected using self-report questionnaires from adult IBD outpatients. Fatigue interference was assessed with the 5-item Fatigue Severity Scale, and scores ≥ 5 were defined as severe fatigue interference. CAM use was assessed with the International CAM Questionnaire. Multivariate logistic regression analysis was used to examine associations between severe fatigue interference and socio-demographic factors, clinical factors, and CAM use.
RESULTS: In total, 428 patients had evaluable questionnaires (response rate 93 %). Severe fatigue interference was reported by 39 % of the total sample. Patients with Crohn's disease (CD) (n = 238) were more likely than patients with ulcerative colitis (UC) (n = 190) to report severe fatigue interference (43 and 33 %, respectively, p = 0.003). In addition, patients reporting severe fatigue interference were more likely to have active disease than patients without severe fatigue interference (p < 0.001 for both diagnoses). Patients with inactive disease had scores comparable to the general population. Factors independently associated with severe fatigue interference in UC included disease activity and CAM use, while in CD they included disease activity and current smoking.
CONCLUSIONS: Severe fatigue interference is common among IBD patients with active disease. Among patients with UC, but not CD, CAM use was associated with severe fatigue interference. The relationship between fatigue interference and personal factors should be considered further in subsequent studies.

Entities:  

Mesh:

Year:  2013        PMID: 23975381     DOI: 10.1007/s11136-013-0508-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  45 in total

1.  Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C.

Authors:  L Kleinman; M W Zodet; Z Hakim; J Aledort; C Barker; K Chan; L Krupp; D Revicki
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls.

Authors:  Lars-Petter Jelsness-Jørgensen; Tomm Bernklev; Magne Henriksen; Roald Torp; Bjørn A Moum
Journal:  Inflamm Bowel Dis       Date:  2010-11-08       Impact factor: 5.325

4.  Crohn's disease and fatigue: constancy and co-variations of activity of the disease, depression, anxiety and subjective quality of life.

Authors:  Ingrid Banovic; Daniel Gilibert; Jacques Cosnes
Journal:  Psychol Health Med       Date:  2010-08       Impact factor: 2.423

5.  Epidemiology and natural history of inflammatory bowel diseases.

Authors:  Jacques Cosnes; Corinne Gower-Rousseau; Philippe Seksik; Antoine Cortot
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

6.  Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale.

Authors:  Anners Lerdal; Astrid Wahl; Tone Rustøen; Berit R Hanestad; Torbjørn Moum
Journal:  Scand J Public Health       Date:  2005       Impact factor: 3.021

Review 7.  The relevance of sleep abnormalities to chronic inflammatory conditions.

Authors:  Z Ranjbaran; L Keefer; E Stepanski; A Farhadi; A Keshavarzian
Journal:  Inflamm Res       Date:  2007-02       Impact factor: 4.575

8.  The contribution of disease severity, depression and negative affectivity to fatigue in multiple sclerosis: a comparison with ulcerative colitis.

Authors:  Yvonne Bol; Annelien A Duits; Christianne E R Vertommen-Mertens; Raymond M M Hupperts; Mariëlle J L Romberg-Camps; Frans R J Verhey; Johan W S Vlaeyen
Journal:  J Psychosom Res       Date:  2010-01-21       Impact factor: 3.006

9.  Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms.

Authors:  Evangelos Kalaitzakis; Eva Carlsson; Axel Josefsson; Ingvar Bosaeus
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

Review 10.  The role of complementary and alternative therapies in managing rheumatoid arthritis.

Authors:  Diana M Taibi; Cheryl Bourguignon
Journal:  Fam Community Health       Date:  2003 Jan-Mar
View more
  10 in total

1.  Pain may be an important factor to consider in inflammatory bowel disease patients troubled by fatigue.

Authors:  Lars-Petter Jelsness-Jørgensen; Svein-Oskar Frigstad; Bjørn Moum; Tore Grimstad; Randi Opheim; Jørgen Jahnsen; Tomm Bernklev
Journal:  United European Gastroenterol J       Date:  2016-10-06       Impact factor: 4.623

2.  Prevalence and factors associated with fatigue in patients with ulcerative colitis in China: a cross-sectional study.

Authors:  Feng Xu; Jingyi Hu; Qian Yang; Yuejin Ji; Cheng Cheng; Lei Zhu; Hong Shen
Journal:  BMC Gastroenterol       Date:  2022-06-03       Impact factor: 2.847

Review 3.  Unmet Needs in IBD: the Case of Fatigue.

Authors:  Pieter Hindryckx; Debby Laukens; Ferdinando D'Amico; Silvio Danese
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

4.  Psychological distress, iron deficiency, active disease and female gender are independent risk factors for fatigue in patients with ulcerative colitis.

Authors:  Börje Jonefjäll; Magnus Simrén; Anders Lasson; Lena Öhman; Hans Strid
Journal:  United European Gastroenterol J       Date:  2017-04-03       Impact factor: 4.623

5.  Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related quality of life.

Authors:  Shellie Jean Radford; Jordan McGing; Wladyslawa Czuber-Dochan; Gordon Moran
Journal:  Frontline Gastroenterol       Date:  2020-01-24

6.  Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue with a nested qualitative element: study protocol for a randomised controlled trial.

Authors:  Micol Artom; Wladyslawa Czuber-Dochan; Jackie Sturt; Christine Norton
Journal:  Trials       Date:  2017-05-11       Impact factor: 2.279

7.  Toward Further Understanding of Crohn's Disease-Related Fatigue: The Role of Depression and Emotional Processing.

Authors:  Ingrid Banovic; Louise Montreuil; Marie Derrey-Bunel; Fabrizio Scrima; Guillaume Savoye; Laurent Beaugerie; Marie-Claire Gay
Journal:  Front Psychol       Date:  2020-04-30

8.  Fatigue as an Extra-Intestinal Manifestation of Celiac Disease: A Systematic Review.

Authors:  Lars-Petter Jelsness-Jørgensen; Tomm Bernklev; Knut E A Lundin
Journal:  Nutrients       Date:  2018-11-03       Impact factor: 5.717

9.  The relationship between the symptom of fatigue and the functioning of patients with inflammatory bowel diseases after surgery.

Authors:  Grażyna Bączyk; Katarzyna A Kozłowska; Dorota Formanowicz; Ewelina Białas; Jacek Karoń; Piotr Krokowicz
Journal:  Prz Gastroenterol       Date:  2019-12-20

10.  Interventions for fatigue in inflammatory bowel disease.

Authors:  Dawn Farrell; Micol Artom; Wladyslawa Czuber-Dochan; Lars P Jelsness-Jørgensen; Christine Norton; Eileen Savage
Journal:  Cochrane Database Syst Rev       Date:  2020-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.